Biosystems Immunolab

Home
Our Company
Diagnostics
- Differential diagnosis of lung cancer
- Lung cancer screening
Services
- Biosystems mAb panel
Technology
News

Bonitas Investment

Biosystems Immunolab → Blog Large Image → News → Bonitas Investment

Oct

Date October 27, 2020

Categories News

Bonitas Investment

Biosystems Immunolab obtains venture capital investment from Bonitás Venture Capital Fund, Fastventures, Ambrichor, and a private investor for the commercialization and further clinical testing of Pulmolisa, Biosystems’ lung cancer test.

Author Biosys

Biosystems Immunolab Zrt.
Simonffy utca 4-6. fszt. 41.
4025 Debrecen,
Hungary

Useful Links

About us
Sitemap

RECENT POST

Protein Atlas January 25, 2022
Collaboration with Ambrichor October 27, 2020

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.